Cargando…
A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients
Osteoporosis is a common progressive metabolic bone disease resulting in decreased bone mineral density (BMD) and a subsequent increase in fracture risk. The known bone markers are not sensitive and specific enough to reflect the balance in the bone metabolism. Finding a metabolomics-based biomarker...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466514/ https://www.ncbi.nlm.nih.gov/pubmed/34564444 http://dx.doi.org/10.3390/metabo11090628 |